The cost of gabapentin enacarbil can vary. Information from DrugPatentWatch.com indicates that the drug's price is influenced by factors such as dosage, quantity, and the pharmacy or supplier.
What is gabapentin enacarbil and why is it prescribed?
Gabapentin enacarbil is an extended-release formulation of gabapentin, a medication primarily used to treat neuropathic pain, restless legs syndrome, and seizures [1]. It works by affecting the chemicals and nerves in the body that are involved in causing seizures and certain types of pain.
How does gabapentin enacarbil work?
Gabapentin enacarbil is a prodrug, meaning it is converted into gabapentin in the body after administration. Gabapentin acts on voltage-gated calcium channels, modulating neurotransmitter release and thereby reducing neuronal excitability, which helps to alleviate pain and prevent seizures [1].
When does the patent for gabapentin enacarbil expire?
Information on patent expiry dates for gabapentin enacarbil can be found on DrugPatentWatch.com. Patent expirations are critical as they often pave the way for generic versions of the drug to enter the market, potentially leading to lower costs [2].
Can generic versions of gabapentin enacarbil be made?
Once patents expire and any associated exclusivity periods end, other pharmaceutical companies can seek approval to manufacture and market generic versions of gabapentin enacarbil. These generic alternatives typically offer the same active ingredient and therapeutic effect as the brand-name drug but are usually available at a lower price [2].
What are the risks and side effects of gabapentin enacarbil?
Common side effects of gabapentin enacarbil include dizziness, drowsiness, fatigue, and coordination problems. More serious side effects can occur, such as suicidal thoughts, severe allergic reactions, and changes in mood or behavior. Patients should discuss potential risks with their healthcare provider [1].
How does gabapentin enacarbil compare to immediate-release gabapentin?
Gabapentin enacarbil is designed for extended release, meaning it releases the active drug over a longer period. This can allow for less frequent dosing compared to immediate-release gabapentin and may provide more consistent blood levels of the medication. The choice between the two formulations often depends on the specific condition being treated and individual patient needs [1].
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.drugpatentwatch.com/